Corteria Pharmaceuticals
Home page - Corteria
Founded 2021 · $84.2M raised
- Founded
- 2021
- Business Model
- B2B
- Website
- corteriapharma.com
- Total Funding
- $84.2M
- Last Round
- $71.0M Series ASep 2023
- Rounds
- 2
About
Privately held pharma company developing first-in-class drugs for cardiovascular and high-unmet-need indications, founded 2021.
Summary
Corteria Pharmaceuticals is a Biotech company, founded in 2021. It has raised $84.2M in total across 2 rounds, most recently a $71.0M Series A round in Sep 2023. Investors include OrbiMed, Jeito Capital and Kurma Partners.
Tech & App Stack
3 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Sep 2023
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company